View Bladder Cancer CME Webcast

View Bladder Cancer CME Webcast. Bladder cancer is not rare. In fact, it is the 4th most common cause of cancer in men and is diagnosed in 73,000 Americans every year.  That means that every 3 years, the average primary care physician will have a patient with newly diagnosed bladder cancer.  Here with our moderator Dr. Jim Allen to tell us more are two of Ohio State’s top experts on bladder cancer.  We have Dr. Amir Mortazavi a medical oncologist at the James Cancer Hospital and an Assistant Professor of Internal Medicine at the Ohio State University.  We also have Dr. Kamal Pohar, a urologic oncologist at the James Cancer Hospital and an Assistant Professor of Internal Medicine at OSU.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY risk factors for bladder cancer; UNDERSTAND the natural history of bladder cancer, the surgical management of early stage bladder cancer, and the methods for prevention of recurrence and progression; and DESCRIBE the optimal multimodality management of muscle-invasive disease.

You’ll also learn about the following:

• Relationship between smoking and bladder cancer
• Screening for bladder cancer
• Metastasis pattern
• Squamous cell carcinoma and adenocarcinoma of the bladder
• Genetic and receptor markers in bladder cancer
• Side effects of BCG
• Chemoprevention for bladder cancer
• Long-term follow up after superficial bladder cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

About these ads